Enactment Of Next Generation Medical Infrastructure Act

JD
Jones Day

Contributor

Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
The "Act Regarding Anonymized Medical Data to Contribute to R&D in the Medical Field" ("Next Generation Medical Infrastructure Act" or "Act") was enacted in Japan on April 28, 2017...
Japan Food, Drugs, Healthcare, Life Sciences

The "Act Regarding Anonymized Medical Data to Contribute to R&D in the Medical Field" ("Next Generation Medical Infrastructure Act" or "Act") was enacted in Japan on April 28, 2017, and was promulgated on May 12, 2017. The Act establishes a system that certifies business operators that can properly and reliably anonymize medical data as certified medical data anonymization agencies ("certified agencies"), in order to promote advanced R&D and new business development relating to health and medical care through secure and proper use of anonymized medical data. For medical institutions, it will become possible to provide medical data to certified agencies if the medical institutions notify their patients in advance and their patients do not reject the provision of that medical data. This Act will come into force within one year from the date of promulgation.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More